USADA announced today that Anthony McLaughlin, 29, of Daniel Island, S.C., an athlete in the sport of weightlifting, has received a four-year suspension for an anti-doping rule violation involving his possession and use or attempted use of multiple prohibited substances. In addition to education and testing, robust anti-doping programs enable investigations stemming from various sources, including tips (Play Clean Tip Line) and whistleblowers. USADA investigations can reveal evidence about the actions of coaches, athletes, and support personnel who have engaged in, instigated, facilitated, or encouraged doping.

This type of information led USADA to discover that McLaughlin purchased three products containing prohibited substances from the online store Wellness Fitness Nutrition on July 21, 2016. The products contained the prohibited substances clomiphene, oxymetholone, and testosterone and were shipped to McLaughlin’s home in South Carolina.

Clomiphene is a Specified Substance in the class of Hormone and Metabolic Modulators, while oxymetholone and testosterone are non-Specified substances in the class of Anabolic Agents. Each of the substances that McLaughlin purchased is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the International Weightlifting Federation Anti-Doping Policy, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.

McLaughlin’s four-year period of ineligibility began on November 24, 2020, the date his sanction was imposed. In addition, McLaughlin has been disqualified from competitive results obtained on and subsequent to July 21, 2016, the date on which he purchased the prohibited substances, including forfeiture of any medals, points and prizes.

• This media release was published by the US Anti-Doping Agency (USADA) on 30 November 2020. Click here for the original.